NVO's Q2 earnings beat but revenues miss estimates as Wegovy and Ozempic face U.S. setbacks and rising competition.

Ozempic isn’t just for weight loss—studies show it could help prevent strokes. Discover what this means for you, and what ...

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to ...

As the list of health benefits of semaglutide drugs grows, perhaps it is time to think about assessing their impact on people ...

European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.

If you’re one of the many people using Ozempic (semaglutide) to manage type 2 diabetes or for weight loss under medical ...

Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, agrees. “Lowering a person’s ...

Novo Nordisk (NVO) offered investors an update about ongoing cost-cutting efforts as copycat weight-loss drugs weigh on sales ...

On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

One of our most valuable natural resources is being lost to age, scalpels, and Ozempic. Here’s everything you need to know ...

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain ...

Cheryl Burke is done staying quiet. The Dancing with the Stars alum, 41, revealed she's been the target of online bullying ...